4//SEC Filing
West Linda 4
Accession 0000899243-22-024971
CIK 0001563577other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:05 PM ET
Size
6.1 KB
Accession
0000899243-22-024971
Insider Transaction Report
Form 4
West Linda
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01+58,496→ 58,496 totalExercise: $1.29Exp: 2032-06-30→ Common Stock (58,496 underlying)
Footnotes (1)
- [F1]This option was awarded pursuant to the "elective option" provisions of the Issuer's non-employee director compensation program for the Reporting Peron's service on the Issuer's Board and certain of its committees. This option shall vest and become exercisable as to 25% of the shares subject to the option upon the Reporting Person completing each three months of continuous service as a Non-Employee Director, or in the applicable committee position, following the date of grant, provided that the fourth and final tranche of the option will vest and become exercisable on the earlier of July 1, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director, or in the applicable committee position, through such vesting date.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001805257
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:05 PM ET
- Size
- 6.1 KB